Literature DB >> 18160814

Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats.

Shigeru Owada1, Sumie Goto, Kenji Bannai, Hideo Hayashi, Fuyuhiko Nishijima, Toshimitsu Niwa.   

Abstract

BACKGROUND/AIM: Indoxyl sulfate (IS) is a uremic toxin that accelerates the progression of chronic renal failure (CRF). This study aimed at determining whether IS impairs antioxidative systems (redox status) in the kidney.
METHODS: IS was orally administered to normal and subtotally nephrectomized (three fourths and five sixths) rats (CRF rats) for 2 weeks. By use of in vivo and ex vivo electron spin resonance spectroscopy, the kidney redox status was evaluated using carbamoyl-PROXYL as a radical spin probe in living rats, and the kidney superoxide scavenging activity was measured. Immunohistochemistry of superoxide dismutase (SOD) in the kidney was performed.
RESULTS: Administration of IS increased serum and kidney levels of IS and serum creatinine and decreased creatinine clearance. CRF rats showed reduced spin reduction rate, prolonged half-life of the spin probe, and reduced superoxide scavenging activity and SOD-positive areas in the kidney as compared with normal rats. Administration of IS further reduced radical spin reduction rate, prolonged half-life of the spin probe, and reduced superoxide scavenging activity and SOD-positive areas in the kidneys.
CONCLUSIONS: Administration of IS reduced superoxide scavenging activity in the kidneys of normal and CRF rats. Thus, the nephrotoxicity of IS may be induced by impairing the antioxidative systems in the kidney. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160814     DOI: 10.1159/000112823

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  21 in total

1.  A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Authors:  Ran-Hui Cha; Shin Wook Kang; Cheol Whee Park; Dae Ryong Cha; Ki Young Na; Sung Gyun Kim; Sun Ae Yoon; Sang Youb Han; Jae Hyun Chang; Sue K Park; Chun Soo Lim; Yon Su Kim
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 8.237

2.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

Review 3.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

4.  Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study.

Authors:  Eiichi Sato; Atsushi Tanaka; Jun-Ichi Oyama; Ayumu Yamasaki; Mitsuhiro Shimomura; Atsushi Hiwatashi; Yoshihiko Ueda; Mayuko Amaha; Mayumi Nomura; Daisuke Matsumura; Tsukasa Nakamura; Koichi Node
Journal:  Heart Vessels       Date:  2015-12-23       Impact factor: 2.037

5.  Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

Authors:  Suguru Yamamoto; Yiqin Zuo; Ji Ma; Patricia G Yancey; Tracy E Hunley; Masaru Motojima; Agnes B Fogo; Macrae F Linton; Sergio Fazio; Iekuni Ichikawa; Valentina Kon
Journal:  Nephrol Dial Transplant       Date:  2011-01-18       Impact factor: 5.992

6.  Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.

Authors:  Suree Lekawanvijit; Andrew R Kompa; Minako Manabe; Bing H Wang; Robyn G Langham; Fuyuhiko Nishijima; Darren J Kelly; Henry Krum
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

Authors:  I-Wen Wu; Kuang-Hung Hsu; Chin-Chan Lee; Chiao-Yin Sun; Heng-Jung Hsu; Chi-Jen Tsai; Chin-Yuan Tzen; Yen-Chih Wang; Ching-Yuang Lin; Mai-Szu Wu
Journal:  Nephrol Dial Transplant       Date:  2010-09-29       Impact factor: 5.992

8.  Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.

Authors:  Badreldin H Ali; Sirin A Adham; Mohammed Al Za'abi; Mostafa I Waly; Javed Yasin; Abderrahim Nemmar; Nicole Schupp
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.

Authors:  Cheng-Jui Lin; Tai-Cherng Liou; Chi-Feng Pan; Pei-Chen Wu; Fang-Ju Sun; Hsuan-Liang Liu; Han-Hsiang Chen; Chih-Jen Wu
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.

Authors:  Kohei Aoki; Yasushi Teshima; Hidekazu Kondo; Shotaro Saito; Akira Fukui; Naoya Fukunaga; Tomoko Nawata; Tatsuo Shimada; Naohiko Takahashi; Hirotaka Shibata
Journal:  J Am Heart Assoc       Date:  2015-10-09       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.